Switch to:

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Vincent J. AngottiN/A567,4910.89%2016-06-01
William J. Dower,PhDN/A201,6290.32%2006-03-15
Dr. Ronald W. Barrett,PhDCEO191,7030.3%2015-09-01
William G. HarrisN/A158,0700.25%2016-02-24
Ms. Gianna M. BoskoN/A92,8370.15%2015-01-13
Dr. Ernest Mario,PhDN/A88,7500.14%2015-05-19
Dr. Pierre V. Tran,M.D.N/A83,3310.13%2005-06-01
Dr. David R. Savello,PhDN/A78,5060.12%2014-01-13
Dr. Paul Goddard,PhDN/A50,831less than 0.1%2005-06-07
Gregory T. BatesN/A45,097less than 0.1%2016-06-01

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Share Ownership Details
Flynn James E2016-02-19Buy20,97311,572,125$3.9983.6877.19
2,158,084 (Through Deerfield Partners, L.P.)
2,746,650 (Through Deerfield International Master Fund, L.P.)
6,667,391 (Through Deerfield Special Situations Fund, L.P.)
Flynn James E2016-02-12Buy4,883,76111,551,152$3.8718900.1682.69
2,148,856 (Through Deerfield Partners, L.P.)
2,734,905 (Through Deerfield International Master Fund, L.P.)
6,667,391 (Through Deerfield Special Situations Fund, L.P.)
Flynn James E2016-01-20Buy346,4176,667,391$4.091416.8572.86
6,667,391 (Through Deerfield Special Situations Fund, L.P.)
Freund John GordonDirector2015-11-11Sell909502,486$6.686.075.8413,899 (Direct)
488,560 (Through Fund)
27 (Beneficial Ownership)
Barrett Ronald WCEO
(Click for the stocks that their CEOs have bought)
2015-09-01Sell12,500359,942$787.51191,703 (Direct)
168,239 (By Trust)
Barrett Ronald WCEO2015-07-15Sell25,000372,442$7.1177.5-0.42204,203 (Direct)
168,239 (By Trust)
WIERENGA WENDALLDirector2015-05-11Buy5,00028,998$5.6328.1525.5828,998 (Direct)
RIEFLIN WILLIAM JLDirector2014-12-10Sell11,010302,845$8.4993.47-16.7321,660 (Direct)
281,117 (By Trust)
68 (Through Fund)
Barrett Ronald WCEO2014-12-08Sell7,015334,682$8.3658.65-15.43166,443 (Direct)
168,239 (By Trust)
BATES GREGORY TSVP, Regulatory Affairs & QA2014-12-08Sell14,16620,747$8.35118.29-15.3320,747 (Direct)
Bosko Gianna MSVP, CLO and Secretary2014-12-05Sell60,00077,072$8.45507-16.3377,072 (Direct)
BATES GREGORY TSVP, Regulatory Affairs & QA2014-09-09Sell5,61220,747$5.2629.5234.4120,747 (Direct)
Freund John GordonDirector2014-06-03Buy12,500498,395$3.9349.1379.98,899 (Direct)
27 (Beneficial Ownership)
489,469 (Through Fund)
FENTON DENNIS MDirector2014-05-27Buy3,00014,300$4.0212.0675.8713,000 (Direct)
1,300 (By Trust)
FRIEDMAN CATHYDirector2014-05-27Buy2,60014,900$3.9210.1980.3612,300 (Direct)
2,600 (By Trust)
WIERENGA WENDALLDirector2014-05-27Buy10,00023,998$3.9939.977.1923,998 (Direct)
MARIO ERNESTDirector2014-05-23Buy30,00083,750$3.73111.989.5483,750 (Direct)
Freund John GordonDirector2014-05-23Buy15,000498,395$3.7355.9589.548,899 (Direct)
27 (Beneficial Ownership)
489,469 (Through Fund)
Barrett Ronald WCEO2014-05-23Buy2,600342,978$3.759.7588.53173,458 (Direct)
168,239 (By Trust)
1,281 (By Children)
BERNS PAUL LDirector2014-05-15Sell2,5005,000$3.669.1593.175,000 (Direct)
BERNS PAUL LDirector2014-04-24Sell2,5002,500$4.310.7564.422,500 (Direct)
BATES GREGORY TSVP, Regulatory Affairs & QA2013-06-14Sell7,50016,540$5.3540.1332.1516,540 (Direct)
MARIO ERNESTDirector2013-05-22Buy20,00030,000$5.49109.828.7830,000 (Direct)
MARIO ERNESTDirector2012-08-09Buy10,00010,000$8.585-16.8210,000 (Direct)
RIEFLIN WILLIAM JLDirector2011-12-16Buy10,000281,117$3.8638.683.16
281,117 (By Trust)
RIEFLIN WILLIAM JLDirector2011-11-21Buy10,000271,117$4.4444.459.23
271,117 (By Trust)
Barrett Ronald WCEO2011-08-11Buy7,500232,590$6.5949.437.2848,851 (Direct)
183,739 (By Trust)
FENTON DENNIS MDirector2010-11-12Buy1,3001,300$7.9110.28-10.62Link
Cundy Kenneth CSVP, Preclinical Development2010-02-01Sell2,00014,861$18.5137.02-61.8Link
Cundy Kenneth CSVP, Preclinical Development2010-01-04Sell2,00013,793$19.1838.36-63.14Link
Cundy Kenneth CSVP, Preclinical Development2009-09-17Sell1,00013,792$24.6324.63-71.3Link
Freund John GordonDirector2009-07-10Buy135,0006,200$192565-62.79
Cundy Kenneth CSVP, Preclinical Development2009-07-01Sell1,00013,792$23.2823.28-69.63
Cundy Kenneth CSVP, Preclinical Development2009-07-01Sell1,00013,792$23.2823.28-69.63
Cundy Kenneth CSVP, Preclinical Development2009-06-11Sell1,00013,792$2222-67.86
Cundy Kenneth CSVP, Preclinical Development2009-03-25Sell54413,040$2211.97-67.86
Cundy Kenneth CSVP, Preclinical Development2009-02-02Sell30012,370$26.958.09-73.77
Cundy Kenneth CSVP, Preclinical Development2009-02-02Sell2,70012,670$26.7972.33-73.61
Cundy Kenneth CSVP, Preclinical Development2009-01-02Sell10010,198$27.322.73-74.12
Cundy Kenneth CSVP, Preclinical Development2009-01-02Sell2,90010,298$26.5677.02-73.38
Gallop Mark ASVP, Research2008-12-01Sell1,200117,053$29.9535.94-76.39
Cundy Kenneth CSVP, Preclinical Development2008-11-03Sell1,00010,198$42.0242.02-83.17
Gallop Mark ASVP, Research2008-11-03Sell300118,253$41.9512.59-83.15
Gallop Mark ASVP, Research2008-11-03Sell2,700118,553$42.05113.54-83.19
Cundy Kenneth CSVP, Preclinical Development2008-10-01Sell3,00010,198$48.74146.22-85.49
Gallop Mark ASVP, Research2008-10-01Sell200121,253$48.879.77-85.53
Gallop Mark ASVP, Research2008-10-01Sell2,800121,453$48.65136.22-85.47
Gallop Mark ASVP, Research2008-09-12Sell1,000124,253$5050-85.86
Harris William GSVP, Finance and CFO2008-09-02Sell1,50030,782$49.0573.58-85.59
Gallop Mark ASVP, Research2008-09-02Sell3,000125,253$49.09147.27-85.6
Cundy Kenneth CSVP, Preclinical Development2008-09-02Sell3,00010,198$49.07147.21-85.59
WIERENGA WENDALLDirector2008-08-19Sell4,0003,998$48.54194.16-85.43
Gallop Mark ASVP, Research2008-08-14Sell1,000128,253$5050-85.86
Cundy Kenneth CSVP, Preclinical Development2008-08-14Sell1,00010,198$4949-85.57
Cundy Kenneth CSVP, Preclinical Development2008-08-01Sell2,00010,198$45.8891.76-84.59
Harris William GSVP, Finance and CFO2008-08-01Sell1,50032,282$45.8768.81-84.59
Gallop Mark ASVP, Research2008-08-01Sell2,500129,753$45.82114.55-84.57
Gallop Mark ASVP, Research2008-08-01Sell2,500129,753$45.82114.55-84.57
Gallop Mark ASVP, Research2008-08-01Sell500129,253$46.0223.01-84.64
Cundy Kenneth CSVP, Preclinical Development2008-07-23Sell1,00010,198$44.5144.51-84.12
Harris William GSVP, Finance and CFO2008-07-23Sell50033,782$4522.5-84.29
Gallop Mark ASVP, Research2008-07-14Sell1,000132,253$40.1640.16-82.4
Cundy Kenneth CSVP, Preclinical Development2008-07-01Sell1,00010,198$38.138.1-81.44
Harris William GSVP, Finance and CFO2008-07-01Sell1,00034,282$38.0838.08-81.43
Gallop Mark ASVP, Research2008-07-01Sell2,000133,253$38.0976.18-81.44
BERNS PAUL LDirector2008-06-16Sell12,5000$42.02525.25-83.17
Harris William GSVP, Finance and CFO2008-06-02Sell1,00035,282$41.8741.87-83.11
Gallop Mark ASVP, Research2008-06-02Sell300135,253$41.9612.59-83.15
Gallop Mark ASVP, Research2008-06-02Sell2,700135,553$41.86113.02-83.11
Cundy Kenneth CSVP, Preclinical Development2008-06-02Sell1,00010,198$41.8741.87-83.11
Cundy Kenneth CSVP, Preclinical Development2008-05-14Sell1,0009,945$44.0444.04-83.95
Harris William GSVP, Finance and CFO2008-05-14Sell50036,210$45.0622.53-84.31
Freund John GordonDirector2008-05-13Buy353,3331,058,257$42.4414995.45-83.34
Savello David RSVP, Development2008-05-12Sell11,19214,540$42.84479.47-83.5
Cundy Kenneth CSVP, Preclinical Development2008-05-01Sell1,00010,945$42.6142.61-83.41
Harris William GSVP, Finance and CFO2008-05-01Sell1,00036,710$42.5942.59-83.4
Gallop Mark ASVP, Research2008-05-01Sell200138,253$42.488.5-83.36
Gallop Mark ASVP, Research2008-05-01Sell2,800138,453$42.57119.2-83.39
Cundy Kenneth CSVP, Preclinical Development2008-04-04Sell1,00011,945$44.1744.17-83.99
Cundy Kenneth CSVP, Preclinical Development2008-04-01Sell1,00012,945$42.0942.09-83.2
Gallop Mark ASVP, Research2008-04-01Sell3,000141,253$41.89125.67-83.12
Harris William GSVP, Finance and CFO2008-04-01Sell1,00037,710$42.0642.06-83.19
FRIEDMAN CATHYDirector2008-03-14Buy2,3002,300$42.7698.35-83.47
Freund John GordonDirector2008-03-14Buy7,5782,720$41.61315.32-83.01
Cundy Kenneth CSVP, Preclinical Development2008-03-03Sell30013,945$50.6415.19-86.04
Cundy Kenneth CSVP, Preclinical Development2008-03-03Sell2,70014,245$50.7136.89-86.06
Gallop Mark ASVP, Research2008-03-03Sell1,100144,253$50.7355.8-86.06
Gallop Mark ASVP, Research2008-03-03Sell2,900145,353$50.71147.06-86.06
Harris William GSVP, Finance and CFO2008-03-03Sell1,50038,710$50.7476.11-86.07
Barrett Ronald WCEO, Director2008-02-19Sell1,28170,786$54.7970.19-87.1
Barrett Ronald WCEO, Director2008-02-19Sell3,66472,067$54.27198.85-86.97
Barrett Ronald WCEO, Director2008-02-19Sell3,05575,731$54.26165.76-86.97
Cundy Kenneth CSVP, Preclinical Development2008-02-01Sell1,50016,275$61.7292.58-88.55
Cundy Kenneth CSVP, Preclinical Development2008-02-01Sell2,50017,775$61.85154.63-88.57
Harris William GSVP, Finance and CFO2008-02-01Sell1,50039,376$61.7292.58-88.55
Gallop Mark ASVP, Research2008-02-01Sell1,285148,253$61.7379.32-88.55
Gallop Mark ASVP, Research2008-02-01Sell2,715149,538$61.75167.65-88.55
Barrett Ronald WCEO, Director2008-01-16Sell1,50078,786$60.7891.17-88.37
Barrett Ronald WCEO, Director2008-01-16Sell3,20080,286$60.98195.14-88.41
Barrett Ronald WCEO, Director2008-01-16Sell3,30083,486$60.76200.51-88.36
Cundy Kenneth CSVP, Preclinical Development2008-01-02Sell1,10020,275$55.9961.59-87.37
Cundy Kenneth CSVP, Preclinical Development2008-01-02Sell2,90021,375$56.04162.52-87.38
Gallop Mark ASVP, Research2008-01-02Sell1,102152,253$55.9561.66-87.36
Gallop Mark ASVP, Research2008-01-02Sell2,898153,355$56.01162.32-87.38
Harris William GSVP, Finance and CFO2008-01-02Sell1,50040,876$56.0384.05-87.38
Barrett Ronald WCEO, Director2007-12-17Sell10088,786$54.765.48-87.09
Barrett Ronald WCEO, Director2007-12-17Sell4,20088,886$54.48228.82-87.02
Barrett Ronald WCEO, Director2007-12-17Sell3,70093,086$54.47201.54-87.02
WIERENGA WENDALLDirector2007-12-05Sell3,0007,998$54.76164.28-87.09
Cundy Kenneth CSVP, Preclinical Development2007-12-03Sell1,00024,275$53.8153.81-86.86
Cundy Kenneth CSVP, Preclinical Development2007-12-03Sell3,00025,275$53.02159.06-86.67
Harris William GSVP, Finance and CFO2007-12-03Sell1,50042,376$53.3279.98-86.74
Barrett Ronald WCEO, Director2007-11-15Sell1,400177,686$54.5776.4-87.04
Barrett Ronald WCEO, Director2007-11-15Sell3,200179,086$54.23173.54-86.96
Barrett Ronald WCEO, Director2007-11-15Sell3,400182,286$54.22184.35-86.96
Cundy Kenneth CSVP, Preclinical Development2007-11-01Sell1,00028,275$49.1149.11-85.6
Cundy Kenneth CSVP, Preclinical Development2007-11-01Sell3,00029,275$49.47148.41-85.71
Harris William GSVP, Finance and CFO2007-11-01Sell1,50043,836$49.4374.15-85.7
Gallop Mark ASVP, Research2007-11-01Sell271156,253$49.6513.46-85.76
Gallop Mark ASVP, Research2007-11-01Sell2,729156,524$49.39134.79-85.69
Barrett Ronald WCEO2007-10-15Sell1,000185,686$49.4949.49-85.71
Barrett Ronald WCEO2007-10-15Sell4,000186,686$49.83199.32-85.81
Barrett Ronald WCEO2007-10-15Sell3,400190,686$49.99169.97-85.86
Harris William GSVP, Finance and CFO2007-10-01Sell1,50045,336$49.373.95-85.66
Gallop Mark ASVP, Research2007-10-01Sell3,000159,253$49.29147.87-85.66
Cundy Kenneth CSVP, Preclinical Development2007-10-01Sell1,00032,275$49.2549.25-85.64
Cundy Kenneth CSVP, Preclinical Development2007-10-01Sell3,00033,275$49.26147.78-85.65
Cundy Kenneth CSVP, Preclinical Development2007-09-18Sell2,00036,275$4590-84.29
Barrett Ronald WCEO2007-09-17Sell3,600194,086$44.28159.41-84.03
Barrett Ronald WCEO2007-09-17Sell4,800197,686$44.3212.64-84.04
Cundy Kenneth CSVP, Preclinical Development2007-09-04Sell2,00038,275$41.8383.66-83.1
Gallop Mark ASVP, Research2007-09-04Sell3,000162,253$41.82125.46-83.09
Barrett Ronald WCEO2007-08-15Sell2,300202,486$39.2690.3-81.99
Barrett Ronald WCEO2007-08-15Sell3,000204,786$39.46118.38-82.08
Barrett Ronald WCEO2007-08-15Sell3,100207,786$39.41122.17-82.06
Gallop Mark ASVP, Research2007-08-01Sell3,000165,253$43.04129.12-83.57
Cundy Kenneth CSVP, Preclinical Development2007-08-01Sell2,00040,275$43.0286.04-83.57
Barrett Ronald WCEO2007-07-16Sell2,217210,886$46.01102-84.63
Barrett Ronald WCEO2007-07-16Sell3,278213,103$46.13151.21-84.67
Barrett Ronald WCEO2007-07-16Sell2,905216,381$46.04133.75-84.64
Cundy Kenneth CSVP, Preclinical Development2007-07-03Sell2,00042,275$4590-84.29
Gallop Mark ASVP, Research2007-07-02Sell3,000168,253$44.82134.46-84.23
Cundy Kenneth CSVP, Preclinical Development2007-07-02Sell2,00044,275$44.8489.68-84.23
Barrett Ronald WCEO2007-06-15Sell2,200219,286$46.21101.66-84.7
Barrett Ronald WCEO2007-06-15Sell3,300221,486$46.08152.06-84.66
Barrett Ronald WCEO2007-06-15Sell2,900224,786$46.1133.69-84.66
Cundy Kenneth CSVP, Preclinical Development2007-06-04Sell1,50046,275$4567.5-84.29
Savello David RSVP, Development2007-06-04Sell13,43113,827$44.38596.07-84.07
Cundy Kenneth CSVP, Preclinical Development2007-06-01Sell2,50047,775$45.02112.55-84.3
Gallop Mark ASVP, Research2007-06-01Sell3,000171,253$45.04135.12-84.3
Cundy Kenneth CSVP, Preclinical Development2007-05-30Sell2,00050,275$4590-84.29
Cundy Kenneth CSVP, Preclinical Development2007-05-22Sell5,00052,275$42.91214.55-83.52
WIERENGA WENDALLDirector2007-05-16Sell5,00010,998$41.15205.75-82.82
NUSSBACHER KENNETH JDirector2007-05-15Sell10,00033,332$41.64416.4-83.02
Barrett Ronald WCEO2007-05-15Sell1,700227,686$41.7670.99-83.07
Barrett Ronald WCEO2007-05-15Sell3,400229,386$41.85142.29-83.11
Barrett Ronald WCEO2007-05-15Sell3,300232,786$41.82138.01-83.09
Gallop Mark ASVP, Research2007-05-14Sell8,00012,660$40.85326.8-82.69
ROBERTS BRYAN EDirector2007-05-10Sell700$41.112.88-82.8
Cundy Kenneth CSVP, Preclinical Development2007-05-01Sell2,00051,211$41.783.4-83.05
Gallop Mark ASVP, Research2007-05-01Sell3,000176,253$41.69125.07-83.04
Cundy Kenneth CSVP, Preclinical Development2007-04-26Sell10053,211$44.244.42-84.02
Cundy Kenneth CSVP, Preclinical Development2007-04-25Sell90053,311$37.8834.09-81.34
Gallop Mark ASVP, Research2007-04-25Sell1,000179,253$38.2638.26-81.52
Barrett Ronald WCEO2007-04-25Sell2,700236,086$38.12102.92-81.45
Barrett Ronald WCEO2007-04-16Sell1,900238,786$29.7556.53-76.24
Barrett Ronald WCEO2007-04-16Sell3,800240,686$29.75113.05-76.24
Cundy Kenneth CSVP, Preclinical Development2007-04-02Sell1,00054,211$27.8127.81-74.58
Gallop Mark ASVP, Research2007-04-02Sell3,000180,253$27.883.4-74.57
Barrett Ronald WCEO2007-03-22Sell2,000245,186$2550-71.72
Barrett Ronald WCEO2007-03-22Sell700244,486$2517.5-71.72
Barrett Ronald WCEO2007-03-15Sell3,000247,186$24.6573.95-71.32
Harris William GSVP, Finance and CFO2007-03-14Sell6,84846,727$24.75169.49-71.43
Harris William GSVP, Finance and CFO2007-03-14Sell8,15253,575$24.71201.44-71.39
Gallop Mark ASVP, Research2007-03-09Sell2,00018,660$25.7951.58-72.59
Cundy Kenneth CSVP, Preclinical Development2007-03-01Sell1,00055,211$25.2325.23-71.98
Gallop Mark ASVP, Research2007-03-01Sell3,000183,253$25.2375.69-71.98
Barrett Ronald WCEO2007-02-15Sell1,400250,186$28.2739.58-74.99
Barrett Ronald WCEO2007-02-15Sell4,300251,586$28.23121.39-74.96
Gallop Mark ASVP, Research2007-02-08Sell1,000186,253$3030-76.43
Barrett Ronald WCEO2007-02-08Sell2,700255,886$3081-76.43
Gallop Mark ASVP, Research2007-02-01Sell3,000187,253$24.0372.09-70.58
Cundy Kenneth CSVP, Preclinical Development2007-02-01Sell1,00056,211$24.0424.04-70.59
Barrett Ronald WCEO2007-01-16Sell100258,586$24.612.46-71.27
Barrett Ronald WCEO2007-01-16Sell5,600258,686$24.85139.16-71.55
Cundy Kenneth CSVP, Preclinical Development2007-01-03Sell1,00057,211$24.324.3-70.91
Gallop Mark ASVP, Research2007-01-03Sell3,000190,253$24.3272.96-70.93
Cundy Kenneth CSVP, Preclinical Development2006-12-22Sell1,00058,211$25.0125.01-71.73
Barrett Ronald WCEO2006-12-15Sell1,400264,286$25.1835.25-71.92
Barrett Ronald WCEO2006-12-15Sell4,300265,686$25.2108.36-71.94
WIERENGA WENDALLDirector2006-12-15Sell4,0000$25.02100.08-71.74
Gallop Mark ASVP, Research2006-12-01Sell400193,253$26.1510.46-72.96
Gallop Mark ASVP, Research2006-12-01Sell2,600193,653$26.0567.73-72.86
WIERENGA WENDALLDirector2006-11-06Sell5,00019,998$23.91119.55-70.43
Barrett Ronald WCEO2006-11-01Sell3,000270,756$23.7771.31-70.26
Gallop Mark ASVP, Research2006-11-01Sell100196,253$23.782.38-70.27
Gallop Mark ASVP, Research2006-11-01Sell2,900196,353$23.7668.9-70.24
Barrett Ronald WCEO2006-10-16Sell3,000273,756$23.8871.64-70.39
Gallop Mark ASVP, Research2006-10-02Sell100199,253$20.482.05-65.48
Gallop Mark ASVP, Research2006-10-02Sell2,900199,353$20.6559.89-65.76
Gallop Mark ASVP, Research2006-09-01Sell90222,607$21.761.96-67.51Link
Gallop Mark ASVP, Research2006-09-01Sell2,910202,343$21.7463.26-67.48Link
Gallop Mark ASVP, Research2006-08-29Sell1,000225,607$20.0120.01-64.67Link
Gallop Mark ASVP, Research2006-08-01Sell2,000227,607$16.8733.74-58.09Link
Gallop Mark ASVP, Research2006-07-06Sell1,000228,607$2020-64.65Link
Gallop Mark ASVP, Research2006-07-03Sell2,000229,607$1938-62.79Link
Gallop Mark ASVP, Research2006-06-01Sell3,000251,607$22.366.9-68.3Link
Gallop Mark ASVP, Research2006-05-01Sell3,000234,253$22.5367.59-68.62Link
Gallop Mark ASVP, Research2006-04-03Sell3,000237,253$21.5464.62-67.18Link
Gallop Mark ASVP, Research2006-03-15Sell1,000240,253$20.0220.02-64.69Link
Gallop Mark ASVP, Research2006-03-01Sell2,000241,253$19.0638.12-62.91Link
Harris William GSVP, Finance and CFO2006-02-24Sell2,13061,459$18.7439.92-62.27Link
Harris William GSVP, Finance and CFO2006-02-24Sell19,87063,589$18.48367.2-61.74Link
Gallop Mark ASVP, Research2006-02-01Sell2,000243,253$14.7929.58-52.2Link
Gallop Mark ASVP, Research2006-01-03Sell2,000245,253$17.8435.68-60.37Link
Dower William JVP, Discovery Biology2005-11-16Buy1,540202,629$8.9313.75-20.83Link
Cundy Kenneth CSVP, Preclinical Development2005-11-16Buy1,69456,322$8.9315.13-20.83Link
Gallop Mark ASVP, Research2005-11-16Buy1,733262,986$8.9315.48-20.83Link
Barrett Ronald WCEO2005-11-16Buy2,380279,136$8.9321.25-20.83Link
RIEFLIN WILLIAM JLPresident2005-11-16Buy2,272268,937$8.9320.29-20.83Link
Freund John GordonDirector2005-09-13Buy4,2001,110,559$15.1263.5-53.24Link
Freund John GordonDirector2005-09-07Buy7,4801,106,359$13.0397.46-45.74Link
Freund John GordonDirector2005-09-06Buy1,5202,197,063$1319.76-45.62Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

"Shares" change (fifth column), "Shares Owned Following This (Direct & Indirect)" transactions (sixth column), and "Trade Price ($)" (seventh column) are split adjusted. The "Share Ownership Details" (last column) displayed data is as of reported (also split adjusted).

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK